ArticleNucleic acids research2026
Perturb-seq reveals TCF7 as a transcriptional link between MAPK- and Wnt-driven gene expression.
Ghanem El Kassem, Anja Sieber, Bertram Klinger, Florian Uhlitz, David Steinbrecht, Mirjam van Bentum, Shawez Khan, Jasmine Hillmer, Jennifer von Schlichting, Reinhold Schäfer and 2 more
Abstract read
In one paragraphArticle in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ghanem El KassemInstitute of Molecular Medicine, Section for Molecular Medicine of Signal Transduction, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany.ORCID 0009-0009-2623-0684 Anja SieberInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0001-6588-8547 Bertram KlingerInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Florian UhlitzInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
David SteinbrechtInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Mirjam van BentumInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Shawez KhanInstitute of Molecular Medicine, Section for Molecular Medicine of Signal Transduction, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Jasmine HillmerInstitute of Molecular Medicine, Section for Molecular Medicine of Signal Transduction, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany.
Jennifer von SchlichtingInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Reinhold SchäferComprehensive Cancer Center, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Nils BlüthgenInstitute of Pathology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.ORCID 0000-0002-0171-7447 Michael BoettcherInstitute of Molecular Medicine, Section for Molecular Medicine of Signal Transduction, Faculty of Medicine, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany.ORCID 0000-0003-0986-4465 Funding
Deutsche Forschungsgemeinschaft 530963080Deutsche Forschungsgemeinschaft RTG2424Deutsche Forschungsgemeinschaft TRR186/A18Deutsche Krebshilfe 70114307Deutsche Krebshilfe 70116872Deutschen Konsortium für Translationale KrebsforschungEinstein Stiftung Berlin EVF-BIH-2019-512European Social Fund ZS/2016/08/80642
6 · The paper itselfAbstract
The mitogen-activated protein kinase (MAPK) pathway is a central signaling cascade whose dysregulation contributes to numerous diseases. While its upstream regulation is well studied, the mechanisms by which MAPK activation leads to diverse transcriptional outcomes remain incompletely understood. To address this shortcoming, we mapped the target gene sets controlled by 22 RAF-inducible transcription factors using targeted Perturb-seq and integrated these data with time-resolved transcriptional profiling. Network reconstruction revealed a topology dominated by two central hubs, EGR1 and FOS, which co-regulate partially overlapping target gene sets. In addition, we uncovered a positive feedback loop between EGR1, a canonical RAF-MAPK effector, and TCF7, a transcription factor typically linked to Wnt signaling. Through this interaction, TCF7 emerges as a transcriptional link that integrates MAPK and Wnt pathway inputs. Together, these findings define the architecture of RAF-MAPK-driven transcriptional regulation and demonstrate how cross-talk between oncogenic signaling pathways can be encoded in transcriptional networks.
Indexed as
Gene Expression RegulationMAP Kinase Signaling SystemT Cell Transcription Factor 1Wnt Signaling PathwayAnimalsEarly Growth Response Protein 1Gene Expression ProfilingGene Regulatory NetworksHumansProto-Oncogene Proteins c-fosTranscription, GeneticEarly Growth Response Protein 1EGR1 protein, humanFOS protein, humanProto-Oncogene Proteins c-fosT Cell Transcription Factor 1TCF7 protein, human
Identifiers
PMID42522868
PMCPMC13416742
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390